C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Agomab Therapeutics to Acquire Origo Biopharma

Friday, October 29, 2021

Agomab Therapeutics NV announced that it has entered into a definitive agreement under which it will acquire Origo Biopharma SL a Spanish clinicalstage biotechnology company developing organrestricted small molecule drug candidates targeting the tran...

Ubiquigent Extends And Expands Drug Discovery Collaboration With Bristol Myers Squibb

Friday, October 29, 2021

Ubiquigent Limited announces the extension and expansion of its longterm collaboration with Bristol Myers Squibb Under the terms of the agreement Ubiquigent will provide Bristol Myers Squibb with increased access to its deubiquitylase DUB enzyme inhi...

WuXi Biologics Completes GMP Inspection by Health Canada for Drug Substance Facility

Thursday, October 28, 2021

WuXi Biologics a global company with leading openaccess biologics technology platforms announced that it has completed a remote GMP inspection by Health Canada for its drug substance facility MFG in Wuxi city There were no observations during the ins...

XtalPi and Signet Expand AI Drug Discovery Collaboration to Novel Cancer Target

Thursday, October 28, 2021

Signet Therapeutics and XtalPi Inc a physicsbased AIpowered drug RD company announced the expansion of their AI drug discovery collaboration to include a new firstinclass program against a novel cancer target identified by Signet The two companies en...

Boehringer Ingelheim Partners with Thoeris to Investigate a Novel Approach to Treat Urea Cycle Disorders

Wednesday, October 27, 2021

Boehringer Ingelheim and Thoeris GmbH announce a collaboration and license agreement with the aim to investigate novel firstinclass therapies for patients with urea cycle disorders UCDs UCDs are rare diseases caused by genetic liver dysfunctions lead...

Teva and MODAG Announce Licensing Collaboration for Neurodegenerative Disease Drug Candidate

Wednesday, October 27, 2021

Teva Pharmaceutical Industries Ltd and MODAG GmbH today announced a strategic collaboration on the exclusive worldwide licensing and development of MODAGs lead compound anleb and a related compound sery Anleb targets pathological alphasynuclein oligo...

Tremeau Expands Pipeline with Novel Non-Opioid Compound for the Treatment of Acute Pain

Tuesday, October 26, 2021

Tremeau Pharmaceuticals today announced that the US Patent and Trademark Office USPTO has issued a Notice of Allowance for US Patent Application No Once issued the patent will provide composition of matter patent protection for Tremeaus novel deuter...

Xeris Pharmaceuticals Enters Collaboration Agreement With Merck

Tuesday, October 26, 2021

Xeris Biopharma Holdings Inc a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology neurology and gastroenterology today announced a collaboration agreement with Merck with an option to l...

FDA Approves Genentech’s Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet Age-Related Macular Degeneration (AMD)

Monday, October 25, 2021

Genentech a member of the Roche Group announced that the US Food and Drug Administration FDA has approved Susvimo ranibizumab injection mgmL for intravitreal use via ocular implant for the treatment of people with wet or neovascular agerelated macul...

Mablink Bioscience and Emergence Therapeutics Enter Into a Licensing Agreement to Develop Antibody Drug Conjugate as a Potential Cancer Therapy

Friday, October 22, 2021

Mablink Bioscience SAS a biotechnology company developing a pipeline of ADC based on its proprietary PSARlink druglinker technology and Emergence Therapeutics AG a European biopharmaceutical company developing novel antibody drug conjugate ADC immuno...

Latest Issue
Get instant
access to our latest e-book
Saving Money, Saving Time In Pharma Operations